MLYS: Mineralys Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 605.68
Enterprise Value ($M) 508.41
Book Value ($M) 290.10
Book Value / Share 5.83
Price / Book 2.09
NCAV ($M) 236.41
NCAV / Share 4.75
Price / NCAV 2.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.55
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 8.55
Current Ratio 8.55

Balance Sheet (mrq) ($M)
Current Assets 267.73
Assets 268.25
Liabilities 31.32
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
3 days ago 13G/A Catalys Pacific Fund, LP 17.40 -5.73
3 days ago 13G/A HBM Healthcare Investments (Cayman) Ltd. 4.50 0.00
3 days ago 13G/A TCG Crossover GP II, LLC 5.00 -22.45
02-14 13G Adams Street Partners Llc 5.60
02-12 13D/A Samsara BioCapital, L.P. 10.30 12.61
02-12 13D/A Ra Capital Management, L.p. 9.99 55.59

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 53,398 201,547 26.49
2024-11-14 31,200 177,006 17.63
2024-11-13 31,503 227,856 13.83
2024-11-12 48,630 364,530 13.34
2024-11-11 38,678 318,377 12.15

(click for more detail)

Similar Companies
MGNX – MacroGenics, Inc. MGTX – MeiraGTx Holdings plc
MIST – Milestone Pharmaceuticals Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc.


Financial data and stock pages provided by
Fintel.io